Come Learn About Psychotherapy for PTSD
Come listen to a presentation about research for a treatment for survivors of trauma who have post-traumatic stress disorder. The treatment has been approved by the FDA and is starting Phase 3 of the clinical research process.
The Multidisciplinary Association for Psychedelic Studies (MAPS) is studying whether the drug MDMA, in combination with psychotherapy, can help heal the psychological and emotional damage caused by sexual assault, war, violent crime and other traumas. MDMA is a drug that is chemically related to amphetamine and mescaline and was formerly used in psychotherapy but is now illegal. It is used illicitly for its ability to induce euphoria, relaxation and heightened empathy.
In Phase 2 trials by MAPS with 107 participants, 61 percent no longer qualified for PTSD after MDMA-assisted psychotherapy two months after treatment. After 12 months, 68 percent no longer had PTSD.
- Shannon Clare Carlin, MA, is the training director for MAPS.org and is also a therapist for the clinical trial taking place in Los Angeles.
- Dr. Ryan Stevenson is a psychologist at CSUSM Student Health Counseling Services. He is also an adherence rater for the study.
The presentation is on Tuesday, Nov. 13 from 1:30-3 p.m. in the Kellogg Reading Room (KEL 5400). It's being organized by Student Health and Counseling Services and Veterans Services.
RSVP at https://bit.ly/2ENq7ba